These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase. Moran RG; Colman PD; Rosowsky A; Forsch RA; Chan KK Mol Pharmacol; 1985 Jan; 27(1):156-66. PubMed ID: 3838105 [TBL] [Abstract][Full Text] [Related]
9. Folate analogues as substrates of mammalian folylpolyglutamate synthetase. Schoo MM; Pristupa ZB; Vickers PJ; Scrimgeour KG Cancer Res; 1985 Jul; 45(7):3034-41. PubMed ID: 3873989 [TBL] [Abstract][Full Text] [Related]
10. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells. Johnson TB; Nair MG; Galivan J Cancer Res; 1988 May; 48(9):2426-31. PubMed ID: 2451560 [TBL] [Abstract][Full Text] [Related]
11. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs. McGuire JJ; Piper JR; Coward JK; Galivan J NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of histidine analogues of folic acid and methotrexate as potential folylpolyglutamate synthetase inhibitors. Mao Z; Pan J; Kalman TI J Med Chem; 1996 Oct; 39(21):4340-4. PubMed ID: 8863812 [TBL] [Abstract][Full Text] [Related]
13. Structural specificity of inhibition of human folylpolyglutamate synthetase by ornithine-containing folate analogs. McGuire JJ; Bolanowska WE; Piper JR Biochem Pharmacol; 1988 Oct; 37(20):3931-9. PubMed ID: 3190739 [TBL] [Abstract][Full Text] [Related]
14. 5-deazafolate analogues with a rotationally restricted glutamate or ornithine side chain: synthesis and binding interaction with folylpolyglutamate synthetase. Rosowsky A; Forsch RA; Null A; Moran RG J Med Chem; 1999 Sep; 42(18):3510-9. PubMed ID: 10479284 [TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of human folylpolyglutamate synthetase by suramin. McGuire JJ; Haile WH Arch Biochem Biophys; 1996 Nov; 335(1):139-44. PubMed ID: 8914844 [TBL] [Abstract][Full Text] [Related]
16. DL-beta,beta-difluoroglutamic acid mediates position-dependent enhancement or termination of pteroylpoly(gamma-glutamate) synthesis catalyzed by folylpolyglutamate synthetase. McGuire JJ; Hart BP; Haile WH; Rhee MS; Galivan J; Coward JK Arch Biochem Biophys; 1995 Aug; 321(2):319-28. PubMed ID: 7646057 [TBL] [Abstract][Full Text] [Related]
17. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action. Rumberger BG; Barrueco JR; Sirotnak FM Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741 [TBL] [Abstract][Full Text] [Related]
18. In vitro uptake, anabolism, and cellular retention of 1843U89 and other benzoquinazoline inhibitors of thymidylate synthase. Hanlon MH; Ferone R Cancer Res; 1996 Jul; 56(14):3301-6. PubMed ID: 8764125 [TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inhibition of human folylpolyglutamate synthetase: design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate. Tsukamoto T; Haile WH; McGuire JJ; Coward JK Arch Biochem Biophys; 1998 Jul; 355(1):109-18. PubMed ID: 9647673 [TBL] [Abstract][Full Text] [Related]
20. Human liver folylpolyglutamate synthetase: biochemical characterization and interactions with folates and folate antagonists. Clarke L; Waxman DJ Arch Biochem Biophys; 1987 Aug; 256(2):585-96. PubMed ID: 3619447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]